LaViv Approval History

• FDA approved: Yes (First approved June 21st, 2011)
• Brand name: LaViv
• Generic name: azficel-T
• Company: Fibrocell Science, Inc.
• Treatment for: Wrinkles

Azficel-T is an autologous cellular product indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.

Development History and FDA Approval Process for LaViv

Date	Article
Jun 22, 2011	Fibrocell Science, Inc. Announces FDA Approval for laViv (azficel-T)
Jan 12, 2011	Fibrocell Science, Inc. Announces FDA Accepts for Review Complete Response Submission for Azficel-T
Dec 20, 2010	Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T
Dec 22, 2009	Fibrocell Science, Inc. Receives FDA Complete Response Letter Regarding azficel-T for Wrinkles
Oct 12, 2009	Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
May 12, 2009	Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review
Mar  9, 2009	Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.